Project Grant R01CA311193
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) under its Alcohol Research Programs (CFDA 93.273) awarded $1,403,926 to the University of Michigan on September 15, 2025, to conduct a randomized controlled trial testing the efficacy of an innovative social media-based intervention for high-intensity drinking (HID) among emerging adults. The research initiative will deliver an 8-week motivational interviewing-based intervention through private social...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded $467,581 to The Research Foundation for the State University of New York under the Cancer Cause and Prevention Research program (CFDA 93.393) for a two-year project grant (July 1, 2026 – June 30, 2028). The grant funds a mixed-methods research study examining the mechanisms of substance use (SU) behaviors among young adult (YA) cancer survivors aged 18–39 years. Using an exploratory sequential mixed-methods design with...
- Federal Grant Award Summary The Ohio State University received a $384,524 Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) awarded June 17, 2026, with a completion date of May 31, 2028. The award supports preclinical research and development of a novel immunotherapeutic platform targeting metastatic breast cancer through selective activation of prodrug cytokines within the tumor microenvironment (TME). The research deliverables...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Ohio State University a $373,926 Project Grant under the Cancer Biology Research program (CFDA 93.396) for the period July 1, 2026, through June 30, 2028. This project develops innovative methodology to unravel mechanisms of chromatin assembly and epigenetic inheritance through dual-labeling proteomics. The research addresses a critical scientific barrier by combining threonine-derived non-canonical amino acid tagging...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded The Ohio State University a Project Grant of $474,223 on May 11, 2026, to support research into the mechanisms and neuroprotective targets in alcohol-induced brain injury. The five-year project, scheduled for completion by January 31, 2031, will elucidate brain region- and cell-specific mechanisms underlying alcohol-induced developmental neurotoxicity (AIDN) and develop precision...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $731,503 Project Grant to the Sloan-Kettering Institute for Cancer Research under the Cancer Cause and Prevention Research program (CFDA 93.393) for a five-year randomized controlled trial (RCT) beginning June 1, 2026 and concluding May 31, 2031. The award funds a clinical research initiative developing and testing Brief Behavioral Activation for Older Adult Cancer Survivors (BBA-OACS), an evidence-based psychotherapy...
- Federal Grant Award Summary The Public Health Institute received a $560,567 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective September 20, 2025, with completion targeted for August 31, 2030. This research initiative will deliver comprehensive epidemiological analyses examining the relationships between beverage-specific per capita alcohol consumption—particularly spirits—and alcohol-related...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Missouri System $1.41M under CFDA 93.273 (Alcohol Research Programs) on September 10, 2025, to conduct a longitudinal study titled "Alcohol Consumption, Contexts, and Consequences Across the Transition to Legal Drinking: A Longitudinal EMA Burst Design." The project, which extends through June 30, 2030, will deliver intensive longitudinal research data examining...
- Federal Grant Award Summary The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded the University of Alabama a Project Grant of $2,524,071 on September 23, 2025, for research investigating the neurocomputational mechanisms underlying self-regulation and reinforcement learning in smoking cessation decisions. The four-year project, with completion scheduled for August 31, 2029, will employ computational model-based multimodal neuroimaging...
- Federal Grant Award Summary The National Cancer Institute (CFDA 93.393, Cancer Cause and Prevention Research) awarded a $696,498 Project Grant to The MGH Institute of Health Professions, Inc., effective May 1, 2026 through April 30, 2031, to develop and optimize a multicomponent intervention designed to improve functional recovery and participation in valued activities among breast cancer survivors. Approximately one-third of breast cancer survivors experience restrictions in vocational, social,...
The National Cancer Institute (NCI), under the Trans-NIH Research Support program (CFDA 93.310), awarded The Ohio State University a $647,762 Project Grant on July 14, 2026, to optimize social media messaging targeting young adult women (ages 18–25) regarding breast cancer risks from alcohol consumption. The research project, scheduled for completion by May 31, 2031, will develop and test evidence-based social media messages by combining self-report and psychophysiological measures to identify message features that maximize persuasive impact. The project team will conduct an online experiment with a national sample of young adult women to evaluate the differential effects of risk content (about alcohol consumption) and efficacy content (about why and how to reduce drinking) based on participants' baseline drinking behaviors. The deliverables include optimized social media messages co-created with young adult women, empirical findings on message features that drive behavioral change, and evidence regarding whether tailored messaging approaches are necessary to reach women with varying drinking patterns. This research addresses a significant public health gap: alcohol consumption accounts for an estimated 16% of breast cancer cases in women, yet awareness of this risk is notably low in the target population, and effective population-level intervention strategies remain understudied relative to other cancer risk factors.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $647.8k | 7/14/26 |